Ligand Pharmaceuticals Inc
LGNZZ- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000886163
In the last 90 days, Ligand Pharmaceuticals Inc insiders filed 0 open-market purchases and 5 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Ligand Pharmaceuticals Inc changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 1 | 0 | −1 |
| Shares | 500 | 0 | −500 (−100.0%) |
| Value | $0 | $0 | $0 |
New holders (0)
Institutions that held Ligand Pharmaceuticals Inc at the end of Q3 2022 but not at the end of Q2 2022.
None.
Sold out (1)
Institutions that held Ligand Pharmaceuticals Inc at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Captrust Financial Advisors | 500 | $0 |